Below is a listing of treatments and therapies for epilepsy. Click on one to read more information or connect with others currently using it.
Overview
Nayzilam is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as a short-term treatment for seizure clusters in people 12 years of age and older. Nayzilam is also known by its drug… read more
Overview
Neurontin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures in people three years of age and older. Neurontin is usually prescribed in addition to… read more
Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their quality of… read more
Overview
Oxtellar XR is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures in people six years of age and older. Oxtellar XR may be prescribed as monotherapy (a… read more
Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their quality of… read more
Overview
Peganone is a prescription drug approved by the Food and Drug Administration (FDA) to treat tonic-clonic and complex partial seizures. Peganone is also referred to by its drug name, ethotoin.
Peganone is… read more
Phenobarbital is a prescription medication that has been sold since 1912 for the treatment of seizures. In people with epilepsy, Phenobarbital is used to prevent all types of seizures except absence seizures, and to… read more
Overview
Phenytek is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control generalized tonic-clonic (grand mal) and complex partial-onset seizures. Phenytek is also referred to by its… read more
Overview
Qudexy XR is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut… read more
Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). For people with frequent, disabling partial onset seizures imperfectly controlled by… read more
Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their quality of… read more
Overview
Sabril is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control spasms in infants one month to two years of age and, in combination with other medications, refractory complex… read more
Overview
Tegretol is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures with complex symptomatology, generalized tonic-clonic seizures, and other generalized… read more
Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with anti-epileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their quality of… read more
Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their quality of… read more
Overview
Topamax is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut… read more
Overview
Tranxene is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures in people 10 years of age and older. Tranxene is used in combination with other… read more
Overview
Trileptal is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of partial-onset seizures. Trileptal may be prescribed as monotherapy (a stand-alone drug) or as an… read more
Overview
Trokendi XR is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with… read more
Overview
Approximately 20 percent of people with epilepsy cannot adequately control their seizures with antiepileptic drugs (AEDs). Other people experience serious side effects from AEDs that impact their quality of… read more
Overview
Valium is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat anxiety, muscle spasms, and convulsive disorders. In cases of epilepsy, Valium is sometimes prescribed off-label… read more
Overview
Valtoco is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acutely adults and children 6 years of age and older for intermittent, stereotypic episodes of frequent seizure… read more
Overview
Vimpat is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures in people 4 years of age and older. Vimpat may be prescribed alone or together with other… read more
Overview
Xcopri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with partial-onset seizures. Xcopri is also referred to by its drug name, cenobamate tablets.
Xcopri is… read more
Overview
Zarontin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control absence (petit mal) seizures in epilepsy. Zarontin is frequently prescribed for children with childhood absence… read more
Overview
Zonegran is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures in adults with epilepsy. Zonegran is used in combination with other anticonvulsant… read more
Overview
Zonisade is a prescription medication approved by the U.S. Food and Drug Administration (FDA) as an adjunctive therapy (a therapy used with a primary treatment) to control partial-onset seizures in people 16… read more